Prof Eoin O’Brien looks at the benefits of aliskiren in the treatment of hypertension but says it should not be prescribed with ACE inhibitors or ARBs in diabetic patients.
PCT hopes now pinned on diabetes programme
February 7, 2012 By Leave a Comment
There is “no doubt” the Financial Emergency Measures in the Public Interest (FEMPI) Act, which has seen reductions in GP fees, has had an impact on primary care teams (PCTs), the HSE has accepted.
Why LDL cholesterol is atherogenic
January 25, 2012 By Leave a Comment
Prof Gerald H Tomkin provides an overview of the role played by LDL and the correlation between LDL cholesterol levels and atherosclerotic risk.
Few people recognise need to lose weight
January 24, 2012 By Leave a Comment
By Lloyd Mudiwa. Thousands of Irish people are still failing to recognise that they are overweight or obese and are at increased risk of type II diabetes, heart disease and some cancers, new research has revealed.
Link is found between low water intake and diabetes
November 3, 2011 By Leave a Comment
People who drink less than half a litre of water each day might be a good group for targeted diabetes prevention interventions, a large study suggests.
Two models of care being considered for diabetes
November 2, 2011 By Leave a Comment
By Gary Culliton. Two models of diabetes care — one more Dublin-centric than the other — are currently being considered by a top-level working group.
Management of gestational diabetes mellitus (GDM)
November 1, 2011 By Leave a Comment
Key messages ● Selective screening for GDM should be carried out on identified at risk pregnant women between 24-28 weeks gestation using the 75g oral glucose tolerance test (OGTT). ● Once GDM is diagnosed (see Table 3), patient education, diet and lifestyle alteration, blood glucose monitoring and regular maternal and foetal surveillance is recommended. ● [...]
Quick guide to antenatal care for women with pre-existing type 1 or type 2 diabetes
November 1, 2011 By Leave a Comment
Antenatal Care (Types 1 & 2 diabetes) by trimester 1st Trimester Book as soon as pregnancy is confirmed in combined diabetes/obstetric clinic for diabetes and obstetric assessment Review foetal risk/maternal benefit ratio of present medication, and commence/continue folic acid 5mg daily. Type 2: Commence insulin as necessary Refer to dietitian for initial review Perform baseline [...]
Blood Glucose Monitoring in the Pregnant and non Pregnant population
November 1, 2011 By Leave a Comment
Table 1: WHO recommendations for the diagnostic criteria for diabetes and intermediate hyperglycaemia in the non pregnant population. Diabetes Fasting plasma glucose ≥7.0mmol/l or 2–h plasma glucose* ≥11.1mmol/l Impaired Glucose Tolerance (IGT) Fasting plasma glucose <7.0mmol/l and 2–h plasma glucose* ≥7.8 and <11.1mmol/l Impaired Fasting Glucose (IFG) Fasting plasma glucose 6.1 to 6.9mmol/l and (if [...]
Bydureon reduces cardiovascular risk factors
November 1, 2011 By Leave a Comment
Analyses Find Type 2 Diabetes Patients Treated with Bydureon Experienced Reduction in Cardiovascular Risk Factors Eli Lilly & company (Ireland) ltd. wish to announce that Bydureon (exenatide extended-release for injectable suspension) is now available in Ireland as a one weekly injection for the treatment of type 2 diabetes mellitus in combination with metformin, sulphonylurea, and/or [...]
Loading ...
